BlackRock, Inc. 13D and 13G filings for VYNE Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-07-09 6:05 pm Purchase | 2021-06-30 | 13G | VYNE Therapeutics Inc. VYNE | BlackRock Inc. BLK | 57,649 2.000% | 57,649 (New Position) | Filing |